SEC Form 4 · accession 0001104659-18-041579
AGILE THERAPEUTICS INC · AGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey Gilmore
Officer — General Counsel
Period of report
Jun 20, 2018
Accepted (ET)
Jun 21, 2018 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001261249
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.58 | Jun 20, 2018 | A | 150,000 | A | — | Jun 19, 2028 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1This option was granted on June 20, 2018. 25% of the shares subject to the stock option vested on the date of grant. The remaining shares vest in 3 equal 25% installments on December 31, 2018, June 30, 2019 and December 31, 2019.